Company intelligence / Profile preview

Xinbaino Biotech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Commercial

Overview

Xinbaino Biotech specializes in the development of recombinant protein production processes and related technical services. It was the first domestic company in China dedicated to functional research and application development of recombinant proteins. The company offers comprehensive technical services including gene synthesis, vector construction, fermentation, purification, as well as downstream applications such as antibody drug process platforms. Its main business supports both basic research and biopharmaceutical R&D by providing high-quality proteins and antibodies.

Therapeutic areas: Other
Modalities: Recombinant proteinMonoclonal antibody
Industry: Drug Discovery Services

Partnerships

Not publicly disclosed

Beyond the preview

Go deeper on Xinbaino Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinbaino Biotech.

Explore the full profile